Concentrated Epitope Retrieval Buffer-Reduced pH from Bethyl Laboratories
GIBCO Donor Calf Serum from Invitrogen
...agicMark XP Western Protein Standards are specific...cular weight estimation directly on western blots....e, allowing direct visualization with the same ant...t protein on the blots. Colorimetric, chemilumines...
Genetic Mapping of Disease Genes from Promega
Biology Products:(Date:12/2/2009)... , SINGAPORE, Dec. 2 S*BIO... novel oral JAK2 inhibitor, SB1518, at The America...position in New Orleans. ,, Data will be presen...escalation trial of SB1518 detailing its safety, t...K/PD) profile in dose levels ranging from 100 to 6...
(Date:12/2/2009)... The Scientist, a leading scient...hotometrics’ Evolve “Intelligent&rdquo...s “Top 10 Innovations of 2009. , ...lve ™ EMCCD camera from Photometrics ®...CCD and EMCCD cameras for the life sciences, was r...
(Date:12/1/2009)... , NEW YORK, Dec. 1 Report...port is available in its catalogue: ,, Industr...//www.reportlinker.com/p0164431/Industrial-Enzymes...nzymes market is an oligopoly with few strong play... market activities. Keen competition and commoditi...
(Date:12/1/2009)... , SHANGHAI, Dec. 1 /PRNewswire-Asia/ -- Sh...ShangPharma, a leading China-based Contract Resear...ner of the 2009 Deloitte,Technology Fast 50 China,...gh,tech companies in China. The award is a testame... growth from 2006 to 2008. , The results ...
Breaking Biology Technology:S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 2The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 3Reportlinker Adds Industrial Enzymes - A Global Market Report 2Reportlinker Adds Industrial Enzymes - A Global Market Report 3Reportlinker Adds Industrial Enzymes - A Global Market Report 4Reportlinker Adds Industrial Enzymes - A Global Market Report 5Reportlinker Adds Industrial Enzymes - A Global Market Report 6Reportlinker Adds Industrial Enzymes - A Global Market Report 7Reportlinker Adds Industrial Enzymes - A Global Market Report 8Reportlinker Adds Industrial Enzymes - A Global Market Report 9Reportlinker Adds Industrial Enzymes - A Global Market Report 10Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning Companies 2Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning Companies 3